发明名称 Methods
摘要 A bone-marrow derived stem cell comprising a recombinant nucleic acid capable of expressing, in the bone-marrow derived stem cell or cell derived therefrom, a therapeutic product. The bone-narrow derived stem cell may be used in the treatment of tissue damage, for example liver damage, or in the correction of a genetic defect. The patient may be administered compositions which promote mobilisation of the stem cells and their maturation in to the desired type of differentiated cell. The bone-marrow derived stem cell may comprise a recombinant nucleic acid capable of expressing a cytotoxic product; this may be useful in removing the recombinant cells from the patient if the cells are no longer required.
申请公布号 AU1624302(A) 申请公布日期 2002.07.01
申请号 AU20020016243 申请日期 2001.12.21
申请人 IMPERIAL COLLEGE INNOVATIONS LIMITED 发明人 STUART FORBES;MALCOLM ALISON;NICK WRIGTH;MIKE THEMIS;RICHARD POULSOM;HOWARD THOMAS
分类号 A61K35/12;A61K35/28;A61K38/00;A61K48/00 主分类号 A61K35/12
代理机构 代理人
主权项
地址